The Institut Pasteur Korea said Thursday that it opened Korea’s first global infectious disease specimen resource bank, which will specialize in collecting and distributing infectious disease specimens.The Specimen Resource Bank was licensed on July 24 as a human derivatives bank that legally secure
Dongwha Pharm said Friday it has signed an agreement to acquire a 51 percent stake in Trung Son Pharma, a Vietnamese pharmacy chain operator, to enter the Southeast Asian pharmaceutical and beauty market in earnest.Established in 1997, Trung Son is a pharmacy chain operator operating more than 140 p
Vivozon Pharmaceutical said it has applied for a preliminary review of the Ministry of Food and Drug Safety (MFDS) to approve Unafra (opiranserine), a non-narcotic painkiller.Unafra is an investigational non-narcotic injection-type pain reliever that mitigates moderate or severe pain. It is intended
Cha Vaccine Institute and Pharos iBio have partnered to discover next-generation immunotherapies using artificial intelligence technology.Cha Vaccine Institute is developing immunotherapies utilizing its proprietary immune enhancer platform, L-pampo.In clinical studies, L-pampo has shown strong anti
Roche has made a last-minute change in the reimbursement strategy for its optic neuromyelitis drug Enspryng (satralizumab), drawing attention to whether the company can successfully put it on the list of drugs covered by insurance.The agenda item for reimbursing Enspryng will be tabled at the eighth
Asian aesthetic and cosmetic professionals recently gathered to share the latest trends and procedural know-how, pointing out that knowing the “patient’s needs” is crucial for aesthetic procedures to produce the best results.Last Sunday, they agreed at “2023 HELF in Seoul” at Grand InterContinental
The announcement on Celltrion Healthcare's contract with a U.S. Pharmacy Benefit Manager (PBM) for its Humira biosimilar Yuflyma (adalimumab) is being delayed.On Tuesday, Celltrion Healthcare disclosed the progress concerning its contract with a U.S. PBM on its website. A PBM is an independent priva
The market for Bruton tyrosine kinase (BTK) inhibitors treating B-cell malignancies has been gradually expanding globally, especially with the recent introduction of third-generation drugs.However, even the second-generation drugs are struggling, faced with the high threshold of insurance coverage i
Samsung Bioepis and Organon announced on Wednesday the interchangeable result of its Humira (adilumab) biosimilar, SB5, based on a recently conducted phase 4 study.Clinical interchangeability studies aim to assess whether one product will affect the immune response of the other once the switch betwe
LG Chem has started developing Korea's first hexavalent combined vaccine for infants, which currently depends entirely on imports.The only hexavalent combined vaccine currently available in Korea is Sanofi's Hexaxim.The company said it enrolled the first patient in Korea's phase 1 clinical trial of
Takeda Pharmaceutical Korea said Tuesday that the health insurance coverage criteria for its hemophilia A treatments, Advate and Adynovate injections, has been expanded from Aug. 1. The expanded reimbursement allows Korean patients with hemophilia A with less than 1 percent coagulation factor activi
Hanmi Pharmaceutical is sharpening its next-generation pipeline by changing and expanding the target indications of candidate treatments returned by global companies.Hanmi Pharm said Monday that it had begun preparations to launch efpeglenatide, which it has been developing as a treatment for metabo
BMS Korea said Tuesday that Onureg (azacitidine), a maintenance therapy for acute myeloid leukemia (AML), will be covered by health insurance from this month.Coverage is available for adult patients with AML who have achieved complete remission (CR) or complete remission with incomplete hematologic
Experts agreed at a recent seminar that ultrasound is essential as a guide to improve the safety and accuracy of aesthetic procedures.“Ultrasound is widely used to image many different body parts but is not well used to image facial and neck structures,” said Professor Kim Hee-jin of Yonsei Universi
GC Biopharma said Monday that its immunoglobulin blood product Alyglo (GC5107B, 10-percent intravenous immunoglobulin) has passed the U.S. Food and Drug Administration's preliminary review for marketing authorization.The company added that the U.S. FDA has also initiated the review of GC5107B for fi
Boryung Consumer Healthcare, a subsidiary of Boryung, said Monday that it has launched Boryung Coenzyme Q10 Max, a healthy functional food.Boryung Coenzyme Q10 Max contains the maximum daily amount of coenzyme Q10, which can help reduce blood pressure and antioxidants, and folic acid, which is neces
Shaperon said Monday that it has submitted an investigational new drug (IND) application for a U.S. phase 2 clinical trial of its atopic dermatitis drug candidate NuGel to the U.S. Food and Drug Administration.The multinational phase 2 study will evaluate the drug’s pharmacokinetics, safety, tolerab
AstraZeneca's rare disease unit Alexion has acquired Pfizer's gene therapy portfolio following its recent acquisition of genomic medicine pioneer LogicBio, exposing its ambition to become an industry leader in genomic medicine.AstraZeneca said Friday that Alexion had acquired Pfizer's portfolio of p
Janssen Korea, the pharmaceutical unit of Johnson & Johnson in Korea, said Thursday its multiple myeloma drug Tecvayli (teclistamab) won approval from the Ministry of Food and Drug Safety as monotherapy to treat adult patients with relapsed or refractory multiple myeloma who have received at least t
Daewoong Pharmaceutical said on Thursday that it recorded 307.1 billion won (approximately $ 240.4 million) in sales and 36.2 billion won in operating profit in the second quarter, up 4.5 percent and 7.8 percent, respectively, from the same quarter last year. The company attributed the increase in o